RITUXIMAB OBJECTIVE OUTCOME MEASURES TRIAL IN SLE (ROOTS): A DOUBLE-BLIND RANDOMISED PLACEBO-CONTROLLED FEASIBILITY TRIAL

被引:0
|
作者
Mahmoud, K. [1 ,2 ]
Wilson, M. [1 ,2 ]
Yusof, M. Y. Md [1 ,2 ]
Brown, S. [3 ]
Hensor, E. [1 ,2 ]
Vital, E. [1 ,2 ]
机构
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS trust, NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England
关键词
Randomized control trial; Systemic lupus erythematosus; bDMARD;
D O I
10.1136/annrheumdis-2023-eular.7022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
LB0005
引用
收藏
页码:202 / 202
页数:1
相关论文
共 50 条
  • [1] COLCHICINE TWICE DAILY FOR HAND OSTEOARTHRITIS: RESULTS FROM THE DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED COLOR TRIAL
    Dossing, A.
    Henriksen, M.
    Ellegaard, K.
    Nielsen, S. M.
    Stamp, L.
    Mueller, F. C.
    Kloppenburg, M.
    Haugen, I.
    Mccarthy, G.
    Conaghan, P. G.
    Dahl, L.
    Terslev, L.
    Altman, R.
    Becce, F.
    Ginnerup-Nielsen, E.
    Jensen, L.
    Boesen, M.
    Christensen, R.
    Dal, U.
    Bliddal, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 50 - 50
  • [2] A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss
    Devi, Gayatri
    Massimi, Steve
    Schultz, Sarah
    Rhosrowshahi, Lynn
    Laakso, Ulla K.
    GENDER MEDICINE, 2007, 4 (04) : 352 - 358
  • [3] Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial
    Merrill, Joan T.
    Shanahan, William R.
    Scheinberg, Morton
    Kalunian, Kenneth C.
    Wofsy, David
    Martin, Renee S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (06) : 883 - 889
  • [4] Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
    Wu, Di
    Li, Jing
    Xu, Dong
    Merrill, Joan T.
    van Vollenhoven, Ronald F.
    Liu, Yi
    Hu, Jiankang
    Li, Yang
    Li, Fen
    Huang, Chenghui
    Wang, Guochun
    Li, Xiaomei
    Zhao, Jianhong
    Zhao, Dongbao
    Huang, Cibo
    Liu, Huaxiang
    Wei, Wei
    Shi, Guixiu
    Lu, Fuai
    Zuo, Xiaoxia
    Bi, Liqi
    Li, Zhijun
    Wang, Xiaoxia
    Zhang, Miaojia
    Tie, Ning
    Li, Juan
    Mo, Hanyou
    Fang, Jianmin
    Bao, Chunde
    Zhang, Fengchun
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 475 - 487
  • [5] Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus
    Kayode J. Bello
    Hong Fang
    Parastoo Fazeli
    Waleed Bolad
    Mary Corretti
    Laurence S. Magder
    Michelle Petri
    Rheumatology International, 2013, 33 : 2789 - 2796
  • [6] Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus
    Bello, Kayode J.
    Fang, Hong
    Fazeli, Parastoo
    Bolad, Waleed
    Corretti, Mary
    Magder, Laurence S.
    Petri, Michelle
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2789 - 2796
  • [7] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Hassanien, M.
    Moshrif, A.
    Hetta, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
  • [8] A double-blind, placebo-controlled, glutamine-supplementation trial in growth-faltering Gambian infants
    Williams, Elizabeth A.
    Elia, Marinos
    Lunn, Peter G.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (02): : 421 - 427
  • [9] Acthar Gel (repository corticotropin injection) for persisten5tly active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial
    Askanase, Anca D.
    Zhao, Enxu
    Zhu, Julie
    Connolly-Strong, Erin
    Furie, Richard A.
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [10] Methyl-donor supplementation in women with systemic lupus erythematosus with different nutritional status: the protocol for a randomised, double-blind, placebo-controlled trial
    da Mota, Jhulia C. N. L.
    Carvalho, Lucas M.
    Ribeiro, Amanda A.
    Souza, Leticia L.
    Borba, Eduardo F.
    Roschel, Hamilton
    Gualano, Bruno
    Nicoletti, Carolina F.
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):